Toutes les études
RecrutementPharmacologie Humaine (Phase I) - AutreInterventionnel

A Single Ascending Dose, Single-Centre Study, to Assess Pharmacokinetics, Safety and Tolerability of a Single Intramuscular Dose of Bedaquiline Long-Acting Injection Formulation in Healthy Participants

Doctors are running a study to test a new way of giving a medicine called bedaquiline, which is used to treat tuberculosis (TB). Instead of daily pills, this new version is a long-acting injection. The main goals are to make sure it's safe for people, to understand how the body uses and gets rid of it, and to see if this injection could be a better way to treat TB in the future. The study involves a single injection and will carefully check participants' health. This research is important for finding easier and more effective ways to help people with tuberculosis.

En un coup d'œil

Statut
Recrutement
Phase
Pharmacologie Humaine (Phase I) - Autre
Sponsor
Janssen Cilag International
Objectif d'inscription
32
Démarrer
24 juin 2024

De quoi parle cette étude ?

This study is looking into a new way to give a very important medicine called bedaquiline, which is used to treat tuberculosis (TB). TB is a serious infection, mainly of the lungs, caused by bacteria. Currently, people often have to take medicines for a long time, sometimes every day, which can be difficult.

Researchers are developing a new version of bedaquiline that can be given as a single injection, designed to work in the body for a longer period. This study is the very first time this new injectable form of bedaquiline will be given to people. The main aim is to see if it is safe and well-tolerated, meaning whether people experience any bad side effects.

Another key part of the study is to understand how the body takes in, uses, and gets rid of this new medicine. This is called 'pharmacokinetics'. By understanding this, doctors can figure out the best way to use the medicine in the future. This research is a crucial first step in potentially making TB treatment much simpler and more effective for patients around the world.

Points clés

  • Tests a new, long-lasting injection for TB.
  • First time in healthy people to check safety and how it works.
  • Could make TB treatment easier in the future.
  • For adults aged 18 and over, both men and women.
  • Involves a single injection and careful health checks.

Qui peut être éligible ?

This study is looking for healthy adult volunteers. You must be at least 18 years old to take part, and there's no upper age limit. Both men and women are welcome.

This is a 'first-in-human' study, meaning it's the first time this specific long-acting injection will be given to people. Because of this, they are looking for healthy individuals who don't have tuberculosis or any other major health problems.

Specific medical checks will be done by the study team to make sure it is safe for you to participate. They will be looking for people who are in good overall health.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Avez-vous 18 ans ou plus ?
  2. Are you generally healthy with no major medical conditions?
  3. Êtes-vous en mesure d'assister aux rendez-vous à la clinique d'étude ?
  4. Are you willing to have blood tests and other medical checks?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you decide to take part, you'll visit a clinic where the study is being held. You'll receive a single injection of the new bedaquiline medicine. The medical team will carefully monitor you during your visits.

Throughout the study, you'll have regular check-ups, which include blood tests, urine tests, and possibly other scans to see how your body is reacting to the medicine. The research team will explain everything in detail, including how often you'll need to visit, what each visit involves, and the total length of your participation. They will also keep track of any side effects you might experience.

Risques et avantages potentiels

Participating in a study like this helps advance medical science and could lead to better treatments for tuberculosis in the future. However, there's no direct personal benefit to you as a participant since you do not have TB. There are potential risks, as with any medicine, including side effects from the injection or the drug itself. These will be carefully explained to you. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Emplacements (1)

Certains emplacements de site sont approximatifs. Nous améliorons cela — veuillez vérifier avec l'équipe d'essai avant de vous déplacer.
  • —
    Non vérifié
    Autriche

Questions fréquentes

What is tuberculosis (TB)?

Tuberculosis is a bacterial infection that usually affects the lungs, but can also affect other parts of the body. It can be serious if not treated.

What does 'long-acting injection' mean?

It means the medicine is given as a single shot, but it stays and works in your body for a longer time, potentially replacing daily pills.

Serai-je payé pour participer ?

This information is not provided here, but it's a good question to ask the study team directly.

Do I have to take time off work or school?

The study involves clinic visits, so you may need to arrange your schedule accordingly. The study team can provide details on the time commitment.

Que se passe-t-il si je change d'avis après avoir rejoint ?

You are free to leave the study at any point, for any reason, without needing to explain why. Your medical care will not be affected.

Comment en savoir plus

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "A Single Ascending Dose, Single-Centre Study, to Assess Phar… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.